Inhibiting agents for Bruton's tyrosine kinase
US-10961237-B2 · Mar 30, 2021 · US
Inhibiting agents for bruton's tyrosine kinase
US11858926B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11858926-B2 |
| Application number | US-202217871157-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 22, 2022 |
| Priority date | Apr 14, 2017 |
| Publication date | Jan 2, 2024 |
| Grant date | Jan 2, 2024 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound selected from: or a pharmaceutically acceptable salt, stereoisomer, or a mixture of stereoisomers thereof. 2. The compound of claim 1 , wherein the compound is: 3. The compound of claim 1 , wherein the compound is: 4. The compound of claim 1 , wherein the compound is: 5. The compound of claim 1 , wherein the compound is:
Assignees
Inventors
Classifications
Boronic and borinic acid compounds · CPC title
- C07D403/12Primary
linked by a chain containing hetero atoms as chain links · CPC title
having seven-membered rings, e.g. azelastine, pentylenetetrazole · CPC title
Drugs for disorders of the nervous system · CPC title
Immunomodulators · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11858926B2 cover?
- Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.
- Who is the assignee on this patent?
- Biogen Ma Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D403/12. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).